LeMaitre Vascular
LMAT
41 hedge funds and large institutions have $50.9M invested in LeMaitre Vascular in 2014 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 11 increasing their positions, 12 reducing their positions, and 2 closing their positions.
8% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 12
2% less funds holding
Funds holding: 42 → 41 (-1)
17% less capital invested
Capital invested by funds: $61.5M → $50.9M (-$10.6M)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
Top Sellers
LMAT Hedge Fund Activity: Q3 2014 in Review
41 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in LeMaitre Vascular (LMAT) for Q3 2014, worth a combined $50.9M — down 17% from $61.5M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of LMAT and 1 opened new positions — a net loss of 1 holder — while 12 trimmed existing stakes and 11 added.
The largest buyer was Skylands Capital, adding an estimated $109K. The largest seller was Thompson Davis & Co, cutting an estimated $181K.
- 41 institutional investors held LeMaitre Vascular (LMAT) as of Q3 2014, down from 42 in Q2 2014.
- Funds reported $50.9M of LeMaitre Vascular stock for Q3 2014, down 17% quarter-over-quarter.
- 1 fund opened new LeMaitre Vascular positions in Q3 2014 and 2 closed out, a net change of -1 holder.
- The largest LeMaitre Vascular buyer in Q3 2014 was Skylands Capital, an estimated $109K added.
- The largest LeMaitre Vascular seller in Q3 2014 was Thompson Davis & Co, an estimated $181K sold.
Based on aggregated 13F filings for Q3 2014.